Margo Georgiadis is a CEO-partner at Flagship Pioneering and co-founder and CEO of Montai Health, an AI platform company enabling the predictable discovery of breakthrough small molecule medicines to treat and preempt chronic disease. In these roles, Georgiadis brings extensive expertise in technological innovation and high-performance business transformation and leverages her artificial intelligence and machine learning experience to advance biotech innovation. In this presentation and conversation with Stanford adjunct lecturer Ravi Belani, Georgiadis shares frameworks that Flagship uses to develop deep tech companies and her approach to addressing the challenges of drug discovery.
—-----------------------------------
Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.
CONNECT WITH US
Twitter: https://twitter.com/ECorner
LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/
Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/
YouTube: https://www.youtube.com/user/ecorner
LEARN MORE
eCorner Website: https://ecorner.stanford.edu/
STVP Website: https://stvp.stanford.edu/
Support our mission of providing students and educators around the world with free access to Stanford University’s network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.
